4/28 HIV Lecture, Ch 15, Ch 16 Flashcards
A few historical facts:
When were the first published reports of HIV?
Earliest cases?
First diagnostic test available?
AZT available?
Protease inhibitors licensed?
AIDS mortality declines in US?
When were the first published reports of HIV: 1981
Earliest cases: Probably 1930-50 in Africa, 1950s in US
First diagnostic test available: 1985 (antibody)
AZT available: 1986
Protease inhibitors licensed: 1995
AIDS mortality declines in US: 1997
Estimate of # people living with HIV infection in US?
Globally?
(what is the world’s population?)
US: 1 million
Global: 42 million
World pop’n: 7.2 billion (7200 million)
what are the 3 modes of transmission?
- Sexual
- Parenteral (blood transfusion, IVDU, needle stick)
- Perinatal
There are 2 types of global transmission patterns.
Where do they predominate?
M:F ratios?
Transmission mech? Types of people are infected?
Type I: North America & Europe.
M:F ratio 10:1, homosexual men, IVDUs, rare perinatal cases.
Population seroprevalance <1%
Type II: Sub-Saharan Africa, Haiti.
M:F ratio 1:1, Heterosexual transmission, blood, unsterilized needles, significant perinatal spread
Population seroprevalence > 1%
Local HIV epidemiology: # patients at Dartmouth HIV program?
infected in NH, VT?
Dartmouth HIV treats ~500
NH: 1000
VT: 700
Projections for prevalance in sub-saharan africa? Eastern Eur? India? SE Asia?
sub-saharan africa: thought to be saturated
Eastern Eur, India, SE Asia: predicted to have rapid rise
What are the relative risks of the parental modes of transmission (screened blood, IVDU, needle stick)?
screened blood: < 1/500,000
IVDU: 6/1000
HIV pos needle stick: 3/1000 without prophylaxis
what is the % transmission from mom to child (perinatal)? how can we reduce that risk?
in US: 25%.
With AZT prophylaxis, 8%
With HIV Rx for mother/infant, 1%
in Africa: 35%
What other viruses is HIV closely related to?
Transforming retroviruses: Mammalian, Avian, HTLV-I, HTLV-II
Cytopathic retroviruses (aka lentiviruses): Visna, HIV-2, SIV (simian immunodef virus), HIV-1 (the one we think of as HIV)
Structure of the virus?
Note:
lipid bilayer
Single-stranded HIV RNA
Protease
Integrase
Reverse transcriptase
What is a clade? What are the different subtypes of HIV-1?
Clade = subtype.
HIV-1 Group M (“Major”) is divided into clades:
Africa: subtypes A, B, C
US: subtype B
Thailand: subtypes B and E
What are the important parts of the HIV life cycle for which inhibitors have been developed?
More on this in the HIV Pharm lecture
- Viral penetration and uncoating
- Reverse transcription
- Transcription
- Assembly
- Release -> progeny
What are the 4 main stages of HIV infection?
- Infection
- Seroconversion
- Clinical latency (asymptomatic)
- AIDS (symptomatic)
Describe the Infection stage of HIV
M-(macrophage)-trophic phenotype infects macrophage or dendritic cell (on mucosal surface if sexually transmitted).
Uses both CD4 and CCR5 receptors (aka C5 phenotype).
\Infection spreads to regional lymph nodes.
Describe the Seroconversion stage of HIV
Burst of viremia accompanied by mono-like seroconversion syndrome in up to 50% of patients, 4-8 weeks after infection. Cytotoxic CD8 cells, and also antibody to viral envelope, reduce viral replication to lower “setpoint” which varies in different individuals.
(Viral load is typically 50% lower in women)
Describe the Clinical Latency stage of HIV
Asymptomatic.
Most patients remain free of clinical sx for 10-12 years. Viral load remains stable; CD4 falls slowly at a rate of 50-75 cells/year.
This apparent “steady state” is actually a dynamic process with large scale viral replication leading to progressive emergence of numerous resistant quasi-species (“swarm of HIV”)
Describe the AIDS/symptomatic stage of HIV
Viral phenotype evolves to T-trophic (T-lymphocyte-trophic) phenotype using both CD4 and CXR4 receptors (aka X4 phenotype). Produces marked increase in proportion of infected circulating CD4 lymphocytes and rapid fall in CD4 count to < 200 (defines AIDS).
T trophic (or syncytium inducing =SI) strains also cause clumping of CD4 lymphocytes.
Clinical immunodeficiency becomes apparent with susceptibility to numerous opportunistic infections. Death results 2-3 yrs from opp infections, tumors, and progressive wasting.
What features of human hosts can influence susceptibility to infection?
Specifically, what genetic change reduces infection risk?
what genetic change will delay disease progression?
Genetic polymorphisms in chemokine co-receptor genes:
Infection risk reduced in pts with homozygous deletion in CCR5 (the second receptor for the M-tropic HIV). These pts are essentially immune to HIV
Disease will progress more slowly in pts homozygous for deletion in CCR5 (as above) and for pts with CXCR4 mutations (the second receptor for T-trophic HIV)
Prevention for sexual transmission?
Parenteral transmission?
Perinatal transmission?
Sexual: condoms, education, post-exposure prophylaxis
Parenteral: blood screening, methadone programs, bleach for needles, needle exchange
Perinatal: screening/counseling, C-sections, HIV Rx during preg or at time of delivery
(from student-asked questions in class)
Pt = HIV+, 35yo woman. Lives in trailer in rural West virginia. Presents with blurry vision, floaters, light flashes/changes. On Opthalmic exam, see retinal detachment, white infiltrates, hemorrhage.
What treatments should you use?
(what does she have?)
She has CMV retinitis (opportunistic when CD4 count is < 50)
- IV ganciclovir or oral valganciclovir if mild lesion
- Opthalmic implant if vision is threatened
- Due to low CD4 count, may want to treat prophylactically against other opportunistic infections
- Treat HIV with antiretrovirals
(from student-asked questions in class)
24 year old male, CD4 count = 90. Has AIDS. Does not take his antiretroviral drugs. For past week has had a headache (worst symptom), also has been sweaty and fatigued.
Best method of diagnosis?
(options: Blood culture, MRI, PAS stain, CSF antigen)
Also, what is treatment? Prophylaxis?
Pt has cryptococcal meningitis
Diagnose via CSF antigen
(CSF is under super high pressure, may squirt into the test tube w puncture!)
Tx = ampho B & 5 flucytosine. May put in shunt to unload pressure.
Prophylaxis = fluconazole.
(from student-asked questions in class)
HIV+ patient, CD4 count = 47. Has been swimming in hot spring (in the upper valley). Productive cough with sputum, fever, night sweats, weight loss.
Lung exam: crackles
Culture reveals acid-fast bacteria.
Treatment? Prophylaxis?
Patient has Mycobacterium Avium.
(if patient had been from elsewhere it could have been TB)
Treatment: Clarithromycin + rifabutin + ethambutol (don’t need to know treatment per Lahey)
Prophy: Weekly azithromycin or rifabutin
List the following in approximate descending order of risk of HIV infection:
- IVDU
- fellatio
- cunnilingus
- receptive anal
- receptive vaginal
- insertive anal
- insertive vaginal
- IVDU & receptive anal - tie for first!!
- insertive anal (note everything anal is higher risk than anything vaginal)
- receptive vaginal
- insertive vaginal
- fellatio
- cunnilingus
CDC recommendation for screening of US adults?
recommendation is that all US adults be screened at least once in lifetime for HIV infection regardless of risk factors in an “opt out” fashion.
what is the risk of transmission from mother to child during vaginal birth?
during breastfeeding?
1 in 4 for each
Beyond specific behaviors, what variables modify the likelihood of HIV transmission?
-when infected partner has high viral load (during primary HIV infection)
(though transmission occurs even when load is undetectable)
- mucosal ulceration
- needle stick: severity of injury, degree of soiling, type of needle